Role Of Sub-Tenon Autologous Platelet Rich Plasma Injections In The Treatment Of Rp Associated Cystoid Macular Edema: Interventional Case Series
Pakistan Journal of Ophthalmology · 01.07.2026 · 42 (3)
DOI: 10.36351/pjo.v42i3.2246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Ophthalmology, online erschienen am 01.07.2026. Verfasst von Kashif Jahangir und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
Retinitis pigmentosa (RP)is a progressive degenerative disease that may develop complications such as cystoid macular edema (CME), epiretinal membrane (ERM), and cataracts. Our study aims to use platelet-rich plasma (PRP) to resolve the cystic spaces at the macula by healing the tissue damage done by RP disease and lowering tissue compliance to limit fluid accumulation. Study Design: Interventional Case Series. Place and Duration of Study: Ibrahim Eye Centre, Lahore from December 2024 to March 2025.
Methods
Seven patients (12 eyes) with retinitis pigmentosa–associated CME received three sessions of autologous sub-Tenon PRP injections at 3-week intervals. Baseline evaluation included best-corrected visual acuity (BCVA), fundoscopy, optical coherence tomography (OCT), and intraocular pressure (IOP), all of which were repeated before each session. Final analysis compared pre-treatment findings with those obtained three weeks after the last injection.
Results
OCT demonstrated a statistically significant reduction in central foveal thickness (mean 289.50 ± 124.28 µm pre-treatment vs. 254.42 ± 111.67 µm post-treatment; p = 0.038). Visual outcomes showed improvement in 3 patients and stability in 4 patients, particularly in eyes with resolution of macular edema. No serious adverse events were observed; one patient developed transient IOP elevation.
Conclusion
Sub-Tenon PRP is a safe and potentially effective option for reducing macular edema in RP. However, larger studies with longer follow-up are required to confirm efficacy, evaluate durability of response, and assess the risk of recurrence or progression.
Zitieren
APA
Jahangir, K., Karamat, M. I., Lala, G. E., & Abbas, Z. (2026). Role Of Sub-Tenon Autologous Platelet Rich Plasma Injections In The Treatment Of Rp Associated Cystoid Macular Edema: Interventional Case Series. Pakistan Journal of Ophthalmology, 42(3). https://doi.org/10.36351/pjo.v42i3.2246
Vancouver
Jahangir K, Karamat MI, Lala GE, Abbas Z. Role Of Sub-Tenon Autologous Platelet Rich Plasma Injections In The Treatment Of Rp Associated Cystoid Macular Edema: Interventional Case Series. Pakistan Journal of Ophthalmology. 2026;42(3). doi:10.36351/pjo.v42i3.2246
BibTeX
@article{Jahangir2026,
author = {Jahangir, Kashif and Karamat, Muhammad Irfan and Lala, Gul E and Abbas, Zaigham},
title = {Role Of Sub-Tenon Autologous Platelet Rich Plasma Injections In The Treatment Of Rp Associated Cystoid Macular Edema: Interventional Case Series},
journal = {Pakistan Journal of Ophthalmology},
year = {2026},
volume = {42},
number = {3},
doi = {10.36351/pjo.v42i3.2246}
}
EUVIMED